T-cell Therapy Market 2025 to 2034
T-cell Therapy Market 2025 to 2034
T-cell Therapy Market (By Therapy Type: CAR T-cell Therapy, T Cell Receptor (TCR)-based, Tumor Infiltrating Lymphocytes (TIL)-based; By Indication: Hematologic Malignancies, Solid Tumors, Others; By End User: Hospitals, Cancer Treatment Centers; By Region: North America, LAMEA, Europe, Asia-Pacific) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2035
Customisation Request
Revenue, 2025
USD 10.30 Bn
Forecast Year, 2035
USD 196.21 Bn
CAGR, 2025 - 2035
34.27%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global T-cell therapy market, valued at over USD 10.30 billion in 2025, is projected to surge to approximately USD 196.21 billion by 2035, expanding at a robust CAGR of 34.27%, driven by advancements in immunotherapy and rising cancer prevalence.
T-cell Therapy Market Size Analysis
T-cell Therapy Market Size By Therapy Type 2025 to 2034 (USD Billion)
| Therapy Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| CAR T-cell Therapy | 1.71 | 2.32 | 3.10 | 4.19 | 5.64 | 7.53 | 10.06 | 13.59 | 18.14 | 24.26 |
| T Cell Receptor (TCR)-based | 3.45 | 4.61 | 6.19 | 8.31 | 11.13 | 15.00 | 20.20 | 26.92 | 36.37 | 48.87 |
| Tumor Infiltrating Lymphocytes (TIL)-based | 5.14 | 6.90 | 9.29 | 12.43 | 16.71 | 22.42 | 30.10 | 40.53 | 54.31 | 72.97 |
T-cell Therapy Market Size By Indication 2025 to 2034 (USD Billion)
| Indication | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hematologic Malignancie | 1.74 | 2.31 | 3.12 | 4.14 | 5.65 | 7.55 | 10.15 | 13.65 | 18.16 | 24.27 |
| Solid Tumors | 3.42 | 4.60 | 6.21 | 8.32 | 11.11 | 14.98 | 20.16 | 26.97 | 36.40 | 48.85 |
| Others | 5.14 | 6.92 | 9.24 | 12.47 | 16.72 | 22.41 | 30.04 | 40.42 | 54.24 | 72.99 |
T-cell Therapy Market Size By End User 2025 to 2034 (USD Billion)
| End User | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 3.42 | 4.63 | 6.19 | 8.38 | 11.16 | 15.01 | 20.28 | 27.23 | 36.34 | 48.52 |
| Cancer Treatment Centers | 6.88 | 9.20 | 12.38 | 16.55 | 22.32 | 29.94 | 40.08 | 53.81 | 72.47 | 97.58 |
T-cell Therapy Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.04 | 1.38 | 1.85 | 2.50 | 3.35 | 4.51 | 6.13 | 8.14 | 10.97 | 14.63 |
| LAMEA | 2.06 | 2.77 | 3.73 | 4.98 | 6.72 | 9.02 | 12.04 | 16.21 | 21.76 | 29.34 |
| Europe | 3.09 | 4.15 | 5.57 | 7.48 | 10.04 | 13.46 | 18.15 | 24.27 | 32.64 | 43.76 |
| Asia-Pacific | 4.11 | 5.53 | 7.41 | 9.97 | 13.36 | 17.96 | 24.05 | 32.43 | 43.44 | 58.37 |
T-cell Therapy Market Size to Hit USD 196.21 Billion by 2035
The global t-cell therapy market size surpassed USD 10.30 billion in 2025 and is predicted to reach around USD 196.21 billion by 2035 with a registering a CAGR of 34.27%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
